Treatment of Depression in Acute Coronary Syndromes with Selective Serotonin Reuptake Inhibitors

被引：0
|
作者：
Joost P. van Melle
Peter de Jonge
Maarten P. van den Berg
Harm J. Pot
Dirk J. van Veldhuisen
机构：
[1] University Medical Center Groningen,Department of Cardiology, Thoraxcenter
[2] University of Groningen,Department of Internal Medicine and Psychiatry
[3] University Medical Center Groningen,Department of Psychiatry
[4] University of Groningen,undefined
[5] University Medical Center Groningen,undefined
[6] University of Groningen,undefined
来源：
Drugs | 2006年 / 66卷
关键词：
Acute Coronary Syndrome; Heart Rate Variability; Fluoxetine; Paroxetine; Sertraline;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Depression in patients with acute coronary syndromes (ACS) is common and associated with impaired cardiovascular prognosis in terms of cardiac mortality and new cardiovascular events. It remains unclear whether antidepressant treatment may reverse these effects. In this review, the literature is evaluated on (i) the antidepressant efficacy of selective serotonin reuptake inhibitors (SSRIs) for depression in patients with ACS; (ii) the pleiomorphic effects of SSRIs that may be associated with cardiovascular prognosis; and (iii) the effects of SSRIs on cardiovascular prognosis.
引用
收藏
页码：2095 / 2107
页数：12
相关论文
共 50 条
  • [41] Controversy revisited: selective serotonin reuptake inhibitors in paediatric depression
    Andrade, Chittaranjan
    Bhakta, Savita G.
    Singh, Nagendra M.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2006, 7 (04): : 251 - 260
  • [42] Combination of inositol and serotonin reuptake inhibitors in the treatment of depression
    Levine, J
    Mishori, A
    Susnosky, M
    Martin, M
    Belmaker, RH
    BIOLOGICAL PSYCHIATRY, 1999, 45 (03) : 270 - 273
  • [43] Risperidone augmentation of selective serotonin reuptake inhibitors in major depression
    Ostroff, RB
    Nelson, JC
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (04) : 256 - 259
  • [44] Discontinuation syndromes with selective serotonin reuptake inhibitors - Are there clinically relevant differences?
    Olver, JS
    Burrows, GD
    Norman, TR
    CNS DRUGS, 1999, 12 (03) : 171 - 177
  • [45] Meta-Analysis of Selective Serotonin Reuptake Inhibitors in Patients With Depression and Coronary Heart Disease
    Pizzi, Carmine
    Rutjes, Anne Wilhelmina Saskia
    Costa, Grazia Maria
    Fontana, Fiorella
    Mezzetti, Andrea
    Manzoli, Lamberto
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (07): : 972 - 979
  • [46] Selective Serotonin Reuptake Inhibitors in Patients With Depression and Coronary Heart Disease: A Meta-Analysis.
    Pizzi, Carmine
    Rutjes, Anne Wilhelmina Saskia
    Costa, Grazia Maria
    Fontana, Fiorella
    Mezzetti, Andrea
    Manzoli, Lamberto
    CIRCULATION, 2010, 122 (21)
  • [47] Selective serotonin reuptake inhibitors in patients with depression and coronary heart disease: a meta-analysis
    Pizzi, C.
    Rutjes, A. W. S.
    Costa, G. M.
    Fontana, F.
    Mezzetti, A.
    Manzoli, L.
    EUROPEAN HEART JOURNAL, 2010, 31 : 231 - 231
  • [48] Use of selective serotonin reuptake inhibitors for treatment of depression in pregnancy and breast-feeding
    Nomura, Marcelo Luis
    Carvalho Pinto e Silva, Joao Luis
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2007, 29 (07): : 331 - 334
  • [49] Antiparkinsonian treatment for depression in Parkinson's disease: Are selective serotonin reuptake inhibitors recommended?
    Philippe De Deurwaerdère
    Yuqiang Ding
    Brain Science Advances, 2016, 2 (02) : 138 - 149
  • [50] Efficacy and Safety of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression in Children and AdolescentsPractitioner Review
    Susan C. Sharp
    Jessica A. Hellings
    Clinical Drug Investigation, 2006, 26 : 247 - 255
12345